Skip to the main content.
Request a Quote

Cell Microsystems Acquires Fluxion Biosciences to Broaden Cell Analysis Product and Services Portfolio. Read the Press Release

At Fluxion, we’re passionate about delivering cell-based solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.

IsoFlux CTC and Rare Cell Isolation

Transforming cancer diagnosis through non-invasive blood tests


Concept of biochemistry with dna molecule on blue background-1

At Fluxion, we’re committed to developing liquid CTC and rare cell isolation and analysis solutions. Our goal is to deliver blood tests that provide an accurate, sensitive cancer molecular profile, leading to better treatment decisions and improved patient outcomes.

Fluxion’s IsoFlux CTC and rare cell solutions are used globally by leading research centers in the development of novel assays for early cancer detection, therapy selection, and patient monitoring. 

Liquid Biopsy

IsoFlux System

IsoFlux Kits




The IsoFlux System combines the power of antibody-based magnetic bead separations with the precision of flow cytometry to deliver unmatched CTC recovery efficiency.

More Information

national-cancer-institute-LnvCEXQwC-o-unsplash - Copy-1

Resources Library

Visit the Resources Library for webinars, application notes and publications

Resources Library